Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Caroverine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLNR known ✓ | O43193 | 1/20 | 0.85 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.85 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.85 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.85 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.85 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.46 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 2/20 | 0.85 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.85 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.85 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.85 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.85 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.85 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.85 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.85 |
| ▸ | HTR3A | P46098 | 1/20 | 0.85 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.85 |
| ▸ | GHSR | Q92847 | 1/20 | 0.85 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Caroverine SCHEMBL25946 | 0.92 | DRD3 (1.00) | DRD3MLNRADORA3ADRA2BADRA2C | |
| Caroverine SCHEMBL31128388 | 0.92 | DRD3 (1.00) | DRD3MLNRADORA3ADRA2BADRA2C | |
| Caroverine SCHEMBL2258789 | 0.92 | DRD3 (0.98) | DRD3MLNRADORA3ADRA2BADRA2C | |
| Caroverine SCHEMBL1649725 | 0.91 | DRD3 (0.96) | DRD3MLNRADORA3ADRA2BADRA2C | |
| Caroverine SCHEMBL28086487 | 0.89 | DRD3 (0.89) | DRD3MLNRADORA3ADRA2BADRA2C | |
| Caroverine SCHEMBL11330670 | 0.86 | DRD3 (0.76) | DRD3MLNRADORA3ADRA2BADRA2C | |
| SCHEMBL3881848 | 0.82 | MLNR (0.77) | DRD3MLNRADORA3ADRA2BADRA2C | |
| SCHEMBL3881842 | 0.73 | MLNR (0.62) | DRD3MLNRADORA3ADRA2BADRA2C | |
| SCHEMBL3900890 | 0.73 | PDE4D (0.65) | DRD3MLNRADORA3ADRA2BADRA2C | |
| SCHEMBL7416308 | 0.72 | ALDH1A1 (0.60) | DRD3MLNRADORA3ADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4339452-A | ANTICOAGULANTS | MEDICHEMIE AG (CH) | 1982-07-13 | — | — | US | claimed |
| EP-0542689-B1 | Use of 1-(aminoalkyl)-3-quinoxaline-2-on derivatives for the preparation of neuroprotective compositions | PHAFAG AG (LI) | 1998-09-23 | — | — | EP | disclosed |
| US-5563140-A | Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives for the preparation of neuroprotective compositions | PHAFAG AKTIENGESELLSCHAFT (LI) | 1996-10-08 | — | — | US | disclosed |
| EP-0542689-A1 | Use of 1-(aminoalkyl)-3-quinoxaline-2-on derivatives for the preparation of neuroprotective compositions | PHAFAG AKTIENGESELLSCHAFT (LI) | 1993-05-19 | — | — | EP | disclosed |
| US-4339452-A | ANTICOAGULANTS | MEDICHEMIE AG (CH) | 1982-07-13 | — | — | US | disclosed |
| US-4339452-A | ANTICOAGULANTS | MEDICHEMIE AG (CH) | 1982-07-13 | — | — | US | disclosed |
| US-4339452-A | ANTICOAGULANTS | MEDICHEMIE AG (CH) | 1982-07-13 | — | — | US | disclosed |
| EP-0032564-A1 | Pharmaceutical use of caroverine and/or salts of caroverine, as well as salts of caroverine with xanthine acid remainders and nicotinic acid remainder | MEDICHEMIE AG (CH) | 1981-07-29 | — | — | EP | disclosed |